BiotechTube
Home/Iktos/Quentin Perron
QP

Quentin Perron

Chief Scientific Officer (CSO) & Co-founder

Iktos

Therapeutic Areas

Inflammation & auto-immune diseasesObesity - MetabolismImmuno-oncology

Iktos Pipeline

DrugIndicationPhase
MTHFD2 InhibitorInflammation & auto-immune diseasesLead Optimization
Amylin Receptor ModulatorObesity - MetabolismLead Optimization
SKP2-CKS1 PPI InhibitorImmuno-oncologyHit-to-Lead